Profile
Didier L.
Lanson worked as a Director of European Operations at Immucor, Inc. and as a VP of Global Operations & International Affairs at Systemix, Inc. He also worked as a Consultant at Biotech Ltd.
Former positions of Didier L. Lanson
| Companies | Position | End |
|---|---|---|
Biotech Ltd.
 Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Biotech Ltd. is an Irish pharmaceutical company. The company is located in Ireland. Biotech was acquired by SelfCare, Inc. on November 01, 1994 for $2.10 million. | Corporate Officer/Principal | 2003-06-30 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | 1999-02-28 |
| IMMUCOR, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Immucor, Inc.
 Immucor, Inc. Medical SpecialtiesHealth Technology Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA. | Health Technology |
Biotech Ltd.
Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Biotech Ltd. is an Irish pharmaceutical company. The company is located in Ireland. Biotech was acquired by SelfCare, Inc. on November 01, 1994 for $2.10 million. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
- Stock Market
- Insiders
- Didier L. Lanson
